Top

Health and Quality of Life Outcomes

Published in:

Open Access 01-12-2016 | Research

Many correlates of poor quality of life among substance users entering treatment are not addiction-specific

Authors: Ashley E. Muller, Svetlana Skurtveit, Thomas Clausen

Published in: Health and Quality of Life Outcomes | Issue 1/2016

Abstract

Background

Quality of life (QoL) is an important measure and outcome within chronic disease management and treatment, including substance use disorders (SUD). The aim of this paper was to investigate correlates of poorer QoL of individuals entering SUD treatment in Norway, in order to identify subgroups that may most benefit from different interventions.

Methods

Twenty-one treatment facilities invited all incoming patients to participate. Five hundred forty-nine patients who enrolled between December 2012 and April 2015 are analyzed. QoL, substance use, mental and physical comorbidities, and exercise behaviors were measured. Multinomial regression analysis was used to determine variables significantly associated with poorer QoL.

Results

The majority of both genders (75 %) reported “poor” or “very poor” QoL at intake. Depression showed a strong association with poor QoL (relative risk ratio [RRR] 3.3, 95 % confidence interval [CI] 1.0–10.3) and very poor QoL (RRR 3.8, 1.2–11.8) among women. Physical inactivity among men was associated with very poor QoL (RRR 2.0, 1.1–3.7), as was reporting eating most meals alone (RRR 2.6, 1.4–4.8). Evaluating one’s weight as too low was also associated with poor QoL (RRR 2.0, 1.0-3.9) and very poor QoL (RRR 2.0, 1.1–3.7) among men. Consuming methadone/buprenorphine was a protective factor for men reporting poor QoL (RRR 0.5, 0.3–0.9) and very poor QoL (RRR 0.4, 0.2–0.9), as well as for women reporting very poor QoL (RRR 0.2, 0.0–0.6).

Conclusions

Factors associated with poorer QoL among other healthy and clinical populations, such as impaired social and physical well-being and psychological distress, were also seen associated in this sample. Treatment should be targeted towards patients with these particular vulnerabilities in addition to focusing on substance-related factors, and interventions proven to improve the QoL of other populations with these vulnerabilities should be explored in a SUD context.

The WHOQOL Group. WHOQOL-BREF: Introduction, Administration, Scoring, and Generic Version of the Assessment (P. o. M. Health, Trans.). 1996. p. 18.

Smith K, Larson MJ. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. 2003. 0095-2990 (Print).

Laudet AB. The Case for Considering Quality of Life in Addiction Research and Clinical Practice. Addict Sci Clin Pract. 2011;6(1):44–55.PubMedPubMedCentral

Frisch MB, Cornell J, Villanueva M, Retzlaff PJ. Clinical validation of the Quality of Life Inventory. A measure of life satisfaction for use in treatment planning and outcome assessment. Psychol Assess. 1992;4(1):92–101. doi:10.1037/1040-3590.4.1.92.CrossRef

Foster JH, Powell JE, Marshall EJ, Peters TJ. Quality of Life in alcohol-dependent subjects – a review. [Article]. Qual Life Res. 1999;8(3):255–61.CrossRefPubMed

Tiffany ST, Friedman L, Greenfield SF, Hasin DS, Jackson R. Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. [Research Support, N.I.H., Extramural]. Addiction. 2012;107(4):709–18. doi:10.1111/j.1360-0443.2011.03581.x.CrossRefPubMedPubMedCentral

De Maeyer J, Vanderplasschen W, Broekaert E. Quality of life among opiate-dependent individuals: A review of the literature. Int J Drug Policy. 2010;21(5):364–80. doi:10.1016/j.drugpo.2010.01.010.CrossRefPubMed

Lin CY, Chang KC, W JD, Lee LJH. Quality of life and its determinants for heroin addicts receiving a methadone maintenance program: Comparison with matched referents from the general population. J Formosan Med Assoc. doi:http://dx.doi.org/10.1016/j.jfma.2015.07.007.

Laudet AB, Becker JB, White WL. Don’t Wanna Go Through That Madness No More: Quality of Life Satisfaction as Predictor of Sustained Remission from Illicit Drug Misuse. Subst Use Misuse. 2009;44(2):227–52. doi:10.1080/10826080802714462.CrossRefPubMedPubMedCentral

10.

De Maeyer J, Vanderplasschen W, Lammertyn J, van Nieuwenhuizen C, Sabbe B, Broekaert E. Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatment. Qual Life Res. 2011;20(1):139–50. doi:10.1007/s11136-010-9732-3.CrossRefPubMedPubMedCentral

11.

Colpaert K, De Maeyer J, Broekaert E, Vanderplasschen W. Impact of addiction severity and psychiatric comorbidity on the quality of life of alcohol-, drug- and dual-dependent persons in residential treatment. Eur Addict Res. 2013;19(4):173–83. doi:10.1159/000343098.CrossRefPubMed

12.

Tracy EM, Laudet AB, Min MO, Kim H, Brown S, Jun MK, et al. Prospective patterns and correlates of quality of life among women in substance abuse treatment. Drug Alcohol Depend. 2012;124(3):242–9. doi:10.1016/j.drugalcdep.2012.01.010.CrossRefPubMedPubMedCentral

13.

Carpentier PJ, Krabbe PF, van Gogh MT, Knapen LJ, Buitelaar JK, de Jong CA. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict. 2009;18(6):470–80.CrossRefPubMed

14.

Bizzarri J, Rucci P, Vallotta A, Girelli M, Scandolari A, Zerbetto E, et al. Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst Use Misuse. 2005;40(12):1765–76.CrossRefPubMed

15.

Benaiges I, Prat G, Adan A. Health-related quality of life in patients with dual diagnosis: clinical correlates. [Comparative Study]. Health Qual Life Outcomes. 2012;10:106. doi:10.1186/1477-7525-10-106.CrossRefPubMedPubMedCentral

16.

Russo J, Roy-Byrne P, Jaffe C, Ries R, Dagadakis C, Avery D. Psychiatric status, quality of life, and level of care as predictors of outcomes of acute inpatient treatment. Psychiatr Serv. 1997;48(11):1427–34.CrossRefPubMed

17.

Wendel-Vos GC, Schuit AJ, Tijhuis MA, Kromhout D. Leisure time physical activity and health-related quality of life: cross-sectional and longitudinal associations. Qual Life Res. 2004;13(3):667–77.CrossRefPubMed

18.

Bize R, Johnson JA, Plotnikoff RC. Physical activity level and health-related quality of life in the general adult population: a systematic review. Prev Med. 2007;45(6):401–15. doi:10.1016/j.ypmed.2007.07.017.CrossRefPubMed

19.

Schuch FB, Vasconcelos-Moreno MP, Fleck MP. The impact of exercise on Quality of Life within exercise and depression trials: A systematic review. Mental Health Physical Activity. 2011;4(2):43–8. doi:http://dx.doi.org/10.1016/j.mhpa.2011.06.002.CrossRef

20.

Gillison FB, Skevington SM, Sato A, Standage M, Evangelidou S. The effects of exercise interventions on quality of life in clinical and healthy populations; a meta-analysis. Soc Sci Med. 2009;68(9):1700–10. doi:10.1016/j.socscimed.2009.02.028.CrossRefPubMed

21.

Smith MA, Lynch WJ. Exercise as a potential treatment for drug abuse: evidence from preclinical studies. Front Psychiatry. 2011;2:82. doi:10.3389/fpsyt.2011.00082.CrossRefPubMedPubMedCentral

22.

Sawatzky R, Liu-Ambrose T, Miller WC, Marra CA. Physical activity as a mediator of the impact of chronic conditions on quality of life in older adults. Health Qual Life Outcomes. 2007;5:68. doi:10.1186/1477-7525-5-68.CrossRefPubMedPubMedCentral

23.

Parslow RA, Lewis VJ, Nay R. Successful aging: development and testing of a multidimensional model using data from a large sample of older australians. J Am Geriatr Soc. 2011;59(11):2077–83. doi:10.1111/j.1532-5415.2011.03665.x.CrossRefPubMed

24.

Elavsky S. Physical activity, menopause, and quality of life: the role of affect and self-worth across time. [Research Support, N.I.H., Extramural]. Menopause. 2009;16(2):265–71. doi:10.1097/gme.0b013e31818c0284.CrossRefPubMedPubMedCentral

25.

Zschucke E, Heinz A, Strohle A. Exercise and physical activity in the therapy of substance use disorders. ScientificWorldJournal. 2012;2012:901741. doi:10.1100/2012/901741.CrossRefPubMedPubMedCentral

26.

Schroeder JR, Latkin CA, Hoover DR, Curry AD, Knowlton AR, Celentano DD. Illicit drug use in one’s social network and in one’s neighborhood predicts individual heroin and cocaine use. Ann Epidemiol. 2001;11(6):389–94.CrossRefPubMed

27.

Wasserman DA, Stewart AL, Delucchi KL. Social support and abstinence from opiates and cocaine during opioid maintenance treatment. [Clinical Trial, Randomized Controlled Trial, Research Support, U.S. Gov’t, P.H.S.]. Drug Alcohol Depend. 2001;65(1):65–75.CrossRefPubMed

28.

Anglin MD, Hser YI, Booth MW. Sex differences in addict careers. 4. Treatment. Am J Drug Alcohol Abuse. 1987;13(3):253–80.CrossRefPubMed

29.

Hser YI, Anglin MD, Booth MW. Sex differences in addict careers. 3. Addiction. [Research Support, U S Gov’t, P H S]. Am J Drug Alcohol Abuse. 1987;13(3):231–51.CrossRefPubMed

30.

Eldred CA, Washington MN. Interpersonal relationships in heroin use by men and women and their role in treatment outcome. Int J Addict. 1976;11(1):117–30.CrossRefPubMed

31.

Skjærvø I, Skurtveit S, Clausen T, Bukten A. Substance use pattern, self-control and social network are associated with crime in a substance using population. Drug Alcohol Rev. ((in press)).

32.

Ventegodt S, Andersen NJ, Merrick J. QOL10 for clinical quality-assurance and research in treatment-efficacy: Ten key questions for measuring the global quality of life, self-rated physical and mental health, and self-rated social-, sexual- and working ability. J Altern Med Res. 2009;1(2).

33.

de Boer AGEM, van Lanschot JJB, Stalmeier PFM, van Sandick JW, Hulscher JBF, de Haes JCJM, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res. 2004;13(2):311–20. doi:10.1023/B:QURE.0000018499.64574.1f.CrossRefPubMed

34.

Hanestad BR, Rustøen T, Knudsen Jr Ø, Lerdal A, Wahl AK. Psychometric properties of the WHOQOL-BREF Questionnaire for the Norwegian general population. J Nurs Meas. 2004;12(2):147–59.CrossRefPubMed

35.

Mathiesen E, Nome S, Eisemann M, Richter J. Drinking patterns, psychological distress and quality of life in a Norwegian general population-based sample. [Article]. Qual Life Res. 2012;21(9):1527–36. doi:10.1007/s11136-011-0080-8.CrossRefPubMed

36.

Lauritzen G, Ravndal E. Introduction of the EuropASI in Norway: Clinical and research experiences from a cost‐effectiveness study. J Subst Use. 2004;9(3-4):141–6. doi:10.1080/14659890410001697415.CrossRef

37.

Ravndal E, Lauritzen G. En prospektiv studie av stoffmisbrukere i behandling i Norge [A prospective study of substance abusers in treatment in Norway]. NORDISK ALKOHOL- & NARKOTIKATIDSKRIFT [Nordic Journal of Alcohol and Narcotics]. 2004;21(6):17.

38.

Rugel EJ, Carpiano RM. Gender differences in the roles for social support in ensuring adequate fruit and vegetable consumption among older adult Canadians. Appetite. 2015;92:102–9. doi:http://dx.doi.org/10.1016/j.appet.2015.05.011.CrossRefPubMed

39.

Tani Y, Sasaki Y, Haseda M, Kondo K, Kondo N. Eating alone and depression in older men and women: The JAGES longitudinal survey. Age Ageing. 2015;44:17.CrossRef

40.

Alonso J, Ferrer M, Gandek B, Ware Jr JE, Aaronson NK, Mosconi P, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. [Research Support, Non-U.S. Gov’t]. Qual Life Res. 2004;13(2):283–98.CrossRefPubMed

41.

Pasareanu AR, Opsal A, Vederhus J-K, Kristensen Ø, Clausen T. Quality of life improved following in-patient substance use disorder treatment. Health Qual Life Outcomes. 2015;13:35. doi:10.1186/s12955-015-0231-7.CrossRefPubMedPubMedCentral

42.

Muller AE, Clausen T. Group exercise to improve quality of life among substance use disorder patients. Scand J Public Health. 2015;43(2):6. doi:10.1177/1403494814561819.CrossRef

43.

Pope CG, Pope HG, Menard W, Fay C, Olivardia R, Phillips KA. Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image. 2005;2(4):395–400. doi:10.1016/j.bodyim.2005.09.001.CrossRefPubMedPubMedCentral

44.

Cash TF, Fleming EC. The impact of body image experiences: development of the body image quality of life inventory. Int J Eat Disord. 2002;31(4):455–60.CrossRefPubMed

45.

Kittler JE, Menard W, Phillips KA. Weight concerns in individuals with body dysmorphic disorder. [Research Support, N I H, Extramural]. Eat Behav. 2007;8(1):115–20.CrossRefPubMedPubMedCentral

46.

Rugel EJ, Carpiano RM. Gender differences in the roles for social support in ensuring adequate fruit and vegetable consumption among older adult Canadians. Appetite(0). 2015 doi:http://dx.doi.org/10.1016/j.appet.2015.05.011.

47.

Fleury MJ, Grenier G, Bamvita JM, Tremblay J, Schmitz N, Caron J. Predictors of quality of life in a longitudinal study of users with severe mental disorders. [Multicenter Study, Research Support, Non-U S Gov’t]. Health Qual Life Outcomes. 2013;11(92):1477–7525.

48.

Pinquart M, Sorensen S. Influences of socioeconomic status, social network, and competence on subjective well-being in later life: a meta-analysis. [Meta-Analysis]. Psychol Aging. 2000;15(2):187–224.CrossRefPubMed

49.

McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689–95.CrossRefPubMed

50.

McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100(4):447–58. doi:10.1111/j.1360-0443.2005.01012.x.CrossRefPubMed

51.

Laudet AB, White W. What are your priorities right now? Identifying service needs across recovery stages to inform service development. J Subst Abuse Treat. 2010;38(1):51–9. doi:10.1016/j.jsat.2009.06.003.CrossRefPubMedPubMedCentral

Title: Many correlates of poor quality of life among substance users entering treatment are not addiction-specific
Authors: Ashley E. Muller
Svetlana Skurtveit
Thomas Clausen
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Health and Quality of Life Outcomes / Issue 1/2016
Electronic ISSN: 1477-7525
DOI: https://doi.org/10.1186/s12955-016-0439-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Many correlates of poor quality of life among substance users entering treatment are not addiction-specific

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Socioeconomic health disparities revisited: coping flexibility enhances health-related quality of life for individuals low in socioeconomic status

The impact of type 2 diabetes on health related quality of life in Bangladesh: results from a matched study comparing treated cases with non-diabetic controls

Rasch analysis holds no brief for the use of the Dermatology Life Quality Index (DLQI) in Chinese neurodermatitis patients

Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer

Child maltreatment and quality of life: a study of adolescents in residential care

Analysis on the situation of subjective well-being and its influencing factors in patients with ankylosing spondylitis